Fig. 1From: Willingness to pay for new medicines: a step towards narrowing the gap between NICE and IQWiGDecision rules for setting reimbursement prices by the Institute for Quality and Efficiency in Health Care (IQWiG). A, C, and X are pairs of incremental costs and effects of existing interventions and D’, D”, and D”’ are cost and effect pairs of the new drug. The reference point is ‘no intervention’Back to article page